Congenital hyperinsulinism (CHI) is a rare genetic disorder in which the pancreas secretes excessive insulin. It is characterized by abnormally high blood insulin levels that cause recurrent and severe episodes of low blood sugar (hypoglycemia). The condition is usually diagnosed within the first few months of an infant's life as they exhibit signs of low blood sugar. The main treatment involves using medications such as diazoxide and octreotide to reduce insulin secretion from the pancreas ... Read more

Congenital Hyperinsulinism is a rare genetic disorder characterized by excessive secretion of insulin from the pancreas, leading to recurrent episodes of low blood sugar (hypoglycemia) in infants and children. The condition may require medications, dieting, and surgical removal of part of the pancreas depending on the severity.

The global Congenital Hyperinsulinism Treatment Market is estimated to be valued at US$ 217.74 Mn in 2023 and is expected to exhibit a ... Read more